Aytu BioScience (AYTU) Tops Q1 EPS by 18c

Aytu BioScience (NASDAQ: AYTU) reported Q1 EPS of ($0.06), $0.18 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $27.66 million versus the consensus estimate of $24.8 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance